Clinovo released a new version of ClinCapture, its advanced open source Electronic Data Capture (EDC) system.
Clinovo released a new version of ClinCapture, its advanced open source Electronic Data Capture (EDC) system. ClinCapture 1.0.3 features new functions including Randomization, Dynamic Groups, and Calendared Events. New advanced features will allow ClinCapture’s users to automate processes, such as event scheduling. ClinCapture 1.0.3 reduces overhead for clinical teams and saves them a significant time in study conduct. ClinCapture has also been complemented with an integrated eClinical Suite introducing height plug-and-play modules including ePRO (Patient Reported Outcome), CTMS (Clinical Trial Management System), and a new offline mode.
ClinCapture 1.0.3 was designed to provide sponsor companies with an extensive and scalable solution to streamline their clinical trials. The system is being utilized on registry studies with more than 20,000 patients over 20 years. “ClinCapture 1.0.3 features an extended set of functions without start-up costs, license fees or vendor lock-in”, explains Ale Gicqueau, President & CEO at Clinovo.
With this new release, ClinCapture becomes the first open source Electronic Data Capture (EDC) system with an integrated randomization capability. Developed in collaboration with Randomize.net, the randomization function performs its role efficiently and seamlessly while preserving data integrity and patient safety. Critical patient data is encrypted throughout the randomization workflow. Randomization time and results are securely logged in the study audit log to ensure 21 CFR Part 11 compliance. The randomization function makes ClinCapture compatible with any clinical studies, involving block, stratified, single- or double-blinded randomization. The randomization function is currently utilized on clinical studies with up to 1,700 patients.
The new Calendared Events and Dynamic Groups functions were designed to automate error-prone and time-consuming processes to reduce overhead and accelerate the study conduct. The new Dynamic Groups function allows sponsor companies to create multiple treatment arms in ClinCapture. Subjects are automatically associated with events related to their treatment arm. The Calendared Events function allows users to automatically schedule events at the completion of a reference event. The function integrates automatic reminder emails when the calendared event is about to begin, and automated queries for missed events according to a pre-defined timeframe. The Calendared Events and Dynamic Groups functions reduce clinical teams’ overhead and streamline study conduct.
ClinCapture’s eClinical Suite extends ClinCapture’s capabilities and meets the needs of medical device and pharmaceutical companies looking to run early and late phase clinical trials or registry studies.
See more at:
http://www.clinovo.com/clinovo-releases-clincapture-103-and-its-new-eclinical-suite#sthash.jvkRLTmR.dpuf
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.